Breaking News

Samsung Biologics Obtains Two International Information Security Certifications

Successfully renews ISO 27001 and ISO 27017 certifications.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Samsung Biologics, a contract development and manufacturing organization (CDMO), has successfully renewed its ISO 27001 certification (Information Security Management System) and obtained ISO 27017 certification (Information Security in cloud services) and ISO 37001 certification (Anti-bribery management systems).   An award ceremony was held with the British Standards Institution (BSI) and the British Embassy Seoul at Samsung Biologics’ Songdo headquarters.   Samsung Biologics is the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters